<?xml version="1.0" encoding="UTF-8"?>
<ref id="B27-vaccines-08-00197">
 <label>27.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sui</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Zheng</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>Z.</given-names>
   </name>
  </person-group>
  <article-title>Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant</article-title>
  <source>Arch. Virol.</source>
  <year>2010</year>
  <volume>155</volume>
  <fpage>535</fpage>
  <lpage>544</lpage>
  <pub-id pub-id-type="doi">10.1007/s00705-010-0621-4</pub-id>
  <?supplied-pmid 20195654?>
  <pub-id pub-id-type="pmid">20195654</pub-id>
 </element-citation>
</ref>
